May 18, 2026 08:00AM
May 15, 2026 07:00AM
May 15, 2026 07:00AM
May 13, 2026 08:00AM
Apr 27, 2026 04:05PM
Apr 27, 2026 04:05PM
Mar 10, 2026 08:00AM Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Feb 23, 2026 05:06PM
Feb 23, 2026 05:05PM
Jan 22, 2026 08:00AM
Jan 22, 2026 08:00AM
Jan 12, 2026 07:01AM
Jan 12, 2026 07:00AM
Jan 7, 2026 08:01AM Protara Therapeutics begins phase 3 trial of IV choline chloride
Jan 7, 2026 08:00AM
Jan 7, 2026 03:46AM
Jan 5, 2026 08:01AM
Jan 5, 2026 08:00AM
Dec 3, 2025 08:00AM
Dec 3, 2025 08:00AM
Dec 1, 2025 04:15PM Protara Therapeutics schedules call on TARA-002 trial data
Dec 1, 2025 04:15PM
Nov 20, 2025 06:41AM
Nov 19, 2025 08:00AM
Nov 19, 2025 08:00AM
Nov 18, 2025 04:30PM
Nov 18, 2025 04:30PM
Nov 17, 2025 08:00AM Protara to present TARA-002 trial data at oncology conference
Nov 17, 2025 08:00AM
Nov 10, 2025 08:00AM
Aug 11, 2025 08:00AM
Jun 30, 2025 08:10AM
Jun 30, 2025 08:00AM
Jun 2, 2025 04:04PM
Jun 2, 2025 04:04PM Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer
May 8, 2025 08:00AM
Apr 28, 2025 12:32PM
Apr 26, 2025 10:00AM
Apr 23, 2025 08:00AM
Apr 15, 2025 04:14PM
Apr 15, 2025 04:13PM
Apr 10, 2025 04:07PM Protara Therapeutics (TARA) to present phase 2 analysis of TARA-002 trial
Apr 10, 2025 04:05PM
Mar 19, 2025 08:03AM
Mar 19, 2025 08:00AM
Mar 5, 2025 08:00AM
Jan 13, 2025 08:00AM
Dec 5, 2024 07:01AM
Dec 5, 2024 07:00AM Protara Announces Positive Results from the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
Dec 3, 2024 08:00AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All